Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice

被引：1
|
作者：
Beasley, Richard [1 ,2 ]
Harper, James [1 ]
Masoli, Matthew [3 ]
机构：
[1] Med Res Inst New Zealand, Wellington 6242, New Zealand
[2] Capital & Coast Dist Hlth Board, Wellington, New Zealand
[3] Univ Exeter, Royal Devon & Exeter Hosp, Exeter, Devon, England
来源：
LANCET RESPIRATORY MEDICINE | 2020年 / 8卷 / 05期
关键词：
BENRALIZUMAB; ANTIBODY; SAFETY;
D O I：
10.1016/S2213-2600(20)30051-5
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：425 / 427
页数：4
相关论文
共 50 条
  • [21] Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma
    Agumadu, Vivian C.
    Ramphul, Kamleshun
    Mejias, Stephanie G.
    Sonaye, Ruhi
    Sombans, Shaheen
    Lohana, Petras
    CUREUS, 2018, 10 (08):
  • [22] Anti-interleukin 5 Therapy for Eosinophilic Asthma: a Meta-analysis of Randomized Clinical Trials
    Fa-Ping Wang
    Xiao-Feng Xiong
    Ting Liu
    Su-Yun Li
    De-Yun Cheng
    Hui Mao
    Clinical Reviews in Allergy & Immunology, 2018, 54 : 318 - 330
  • [23] Anti-interleukin 5 Therapy for Eosinophilic Asthma: a Meta-analysis of Randomized Clinical Trials
    Wang, Fa-Ping
    Xiong, Xiao-Feng
    Liu, Ting
    Li, Su-Yun
    Cheng, De-Yun
    Mao, Hui
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (02) : 318 - 330
  • [24] Comparison of anti-interleukin-5 therapies in patients with severe asthma: global and indirect meta-analyses of randomized placebo-controlled trials
    Cabon, Y.
    Molinari, N.
    Marin, G.
    Vachier, I.
    Gamez, A. S.
    Chanez, P.
    Bourdin, A.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (01): : 129 - 138
  • [25] Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis
    Wang, Fa-Ping
    Liu, Ting
    Lan, Zhu
    Li, Su-Yun
    Mao, Hui
    PLOS ONE, 2016, 11 (11):
  • [26] Asthmatherapie mit Anti-Interleukin-5-AntikörperTreatment of asthma with an anti-interleukin-5 antibody
    C. Kroegel
    Der Pneumologe, 2009, 6 (5): : 328 - 329
  • [27] Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: A pairwise and Bayesian network meta-analysis
    He, Lu-Lu
    Zhang, Lei
    Jiang, Lei
    Xu, Feng
    Fei, Dong-Sheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 64 : 223 - 231
  • [28] Prednisone-sparing effect of anti-interleukin-5 in asthma
    Hargreave, FE
    Smith-Blackwell, R
    CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (11): : 1807 - 1807
  • [29] Anti-interleukin-5 antibody therapy in eosinophilic diseases
    Simon, D
    Braathen, LR
    Simon, HU
    PATHOBIOLOGY, 2005, 72 (06) : 287 - 292
  • [30] Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy
    Buhl, R.
    EUROPEAN RESPIRATORY REVIEW, 2007, 16 (104): : 73 - 77
12345